BBNX (Beta Bionics, Inc.) Return on Sales by Gross Profit

BBNX (iLet Bionic Pancreas) - company brandmark

Advance confidence in management during the business scaling phase is driving share price volatility for Beta Bionics Inc (BBNX). The gross margin level confirms this trend, with the parameter mark equal to 58.60. The unit economics of Beta Bionics Inc (BBNX) are based on the sale of autonomous diabetes management systems, while ultimate success depends on the expansion rate of the iLet user base and FDA approvals.

Beta Bionics Inc (BBNX): Gross Margin from 01/31/2025 to 11/20/2026

Comprehensive metric breakdowns and analytics for Beta Bionics Inc (BBNX)

- business market valuation indicators:
Fundamental valuation:BBNX Beta Bionics, Inc.
Finished products of iLet Bionic Pancreas

For the automated diabetes management innovator Beta Bionics Inc. (BBNX), the gross profit margin reflects the monetization efficiency of its unique bionic technologies. This indicator measures the portion of revenue remaining after direct production costs, allowing investors to distinguish a sustainable market advantage from hidden operating expenses and capital freeze risks through an analysis of this chart.

Main competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin PODD|Gross Margin zimmerbiomet.com (ZBH)|Gross Profitability CooperCompanies COO|Gross Margin Invisalign ALGN|GMED - Gross Profitability|TMDX: Gross Profitability|ATEC (Alphatec Holdings, Inc.) - Return on Gross Profit|Artivion, Inc. - Gross Profit Rate|ENOV (Enovis Inc.) - Gross Margin|Gross Profit Margin Integra LifeSciences Corp IART|Gross Profitability Establishment Labs Corp (ESTA)|IRADIMED CORPORATION (IRMD) - Gross Sales Margin|Embecta Health - Return on Gross Profit|Gross Margin Tandem Diabetes Care TNDM|AxoGen Inc - Gross Margin|Return on Sales by Gross Profit SI-BONE Inc SIBN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO